Home/Filings/4/0001645572-18-000006
4//SEC Filing

Eyre Brik V 4

Accession 0001645572-18-000006

CIK 0000010456other

Filed

May 22, 8:00 PM ET

Accepted

May 23, 5:45 PM ET

Size

11.0 KB

Accession

0001645572-18-000006

Insider Transaction Report

Form 4
Period: 2018-05-22
Eyre Brik V
CVP, Hospital Products
Transactions
  • Exercise/Conversion

    Common Stock, $1 par value

    2018-05-22$37.38/sh+25,000$934,50090,115 total
  • Sale

    Common Stock, $1 par value

    2018-05-22$71.96/sh25,000$1,799,00065,115 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2018-05-2215,8280 total
    Exercise: $37.38From: 2017-03-03Exp: 2025-03-03Common Stock, $1 par value (15,828 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2018-05-229,17242,243 total
    Exercise: $37.38From: 2018-03-05Exp: 2025-03-03Common Stock, $1 par value (9,172 underlying)
Footnotes (2)
  • [F1]Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Eyre with respect to certain vested stock options granted by Baxter International Inc. ("BII") to Mr. Eyre.
  • [F2]Price reflects weighted average sales price. Range of prices for transactions are $71.65 through $72.37. Full information regarding the number of shares sold at each separate price will be provided by BII upon request.

Issuer

BAXTER INTERNATIONAL INC

CIK 0000010456

Entity typeother

Related Parties

1
  • filerCIK 0001645572

Filing Metadata

Form type
4
Filed
May 22, 8:00 PM ET
Accepted
May 23, 5:45 PM ET
Size
11.0 KB